[Stent-associated urosepsis, personalized bacteriophage therapy].

Autor: Perepanova T S; N.A. Lopatkin Research Institute of Urology and Interventional Radiology branch of the National Medical Research Radiological Center, Moscow, Russia., Kazachenko A V; N.A. Lopatkin Research Institute of Urology and Interventional Radiology branch of the National Medical Research Radiological Center, Moscow, Russia., Mesropyan S A; N.A. Lopatkin Research Institute of Urology and Interventional Radiology branch of the National Medical Research Radiological Center, Moscow, Russia., Antonova V E; N.A. Lopatkin Research Institute of Urology and Interventional Radiology branch of the National Medical Research Radiological Center, Moscow, Russia., Nazirov M R; N.A. Lopatkin Research Institute of Urology and Interventional Radiology branch of the National Medical Research Radiological Center, Moscow, Russia., Malova Yu A; N.A. Lopatkin Research Institute of Urology and Interventional Radiology branch of the National Medical Research Radiological Center, Moscow, Russia., Lyubchenko L N; N.A. Lopatkin Research Institute of Urology and Interventional Radiology branch of the National Medical Research Radiological Center, Moscow, Russia.

Publikováno v: Urologiia (Moscow, Russia : 1999) [Urologiia] 2024 Sep (4), pp. 97-102.

Genome-Wide Profiling of Endogenous Single-Stranded DNA Using the SSiNGLe-P1 Method.

Autor: Xu D; Institute of Genomics, School of Medicine, Huaqiao University, 668 Jimei Road, Xiamen 361021, China., Huang Y; Institute of Genomics, School of Medicine, Huaqiao University, 668 Jimei Road, Xiamen 361021, China., Luo L; Institute of Genomics, School of Medicine, Huaqiao University, 668 Jimei Road, Xiamen 361021, China., Tang L; Institute of Genomics, School of Medicine, Huaqiao University, 668 Jimei Road, Xiamen 361021, China., Lu M; Institute of Genomics, School of Medicine, Huaqiao University, 668 Jimei Road, Xiamen 361021, China., Cao H; Institute of Genomics, School of Medicine, Huaqiao University, 668 Jimei Road, Xiamen 361021, China., Wang F; Institute of Genomics, School of Medicine, Huaqiao University, 668 Jimei Road, Xiamen 361021, China., Diao Y; Institute of Genomics, School of Medicine, Huaqiao University, 668 Jimei Road, Xiamen 361021, China., Lyubchenko L; National Medical Research Center for Radiology, Ministry of Health of Russia, 125284 Moscow, Russia., Kapranov P; Institute of Genomics, School of Medicine, Huaqiao University, 668 Jimei Road, Xiamen 361021, China.; State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Xiamen 361102, China.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2023 Jul 27; Vol. 24 (15). Date of Electronic Publication: 2023 Jul 27.

Genotyping of BRCA1, BRCA2, and CHEK2 germline mutations in Russian breast cancer patients using diagnostic biochips.

Autor: Nasedkina, T., Gromyko, O., Emelyanova, M., Ignatova, E., Kazubskaya, T., Portnoi, S., Zasedatelev, A., Lyubchenko, L.

Publikováno v: Molecular Biology; Mar2014, Vol. 48 Issue 2, p207-213, 7p

Detection of BRAF , NRAS , KIT , GNAQ , GNA11 and MAP2K1/2 mutations in Russian melanoma patients using LNA PCR clamp and biochip analysis.

Autor: Emelyanova M; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russian Federation., Ghukasyan L; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russian Federation., Abramov I; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russian Federation.; Blokhin Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, Russian Federation., Ryabaya O; Blokhin Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, Russian Federation., Stepanova E; Blokhin Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, Russian Federation., Kudryavtseva A; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russian Federation.; P. Hertsen Moscow Oncology Research Institute, Moscow, Russian Federation., Sadritdinova A; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russian Federation.; P. Hertsen Moscow Oncology Research Institute, Moscow, Russian Federation., Dzhumakova C; Blokhin Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, Russian Federation., Belysheva T; Blokhin Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, Russian Federation., Surzhikov S; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russian Federation., Lyubchenko L; Blokhin Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, Russian Federation., Zasedatelev A; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russian Federation.; Blokhin Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, Russian Federation., Nasedkina T; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russian Federation.; Blokhin Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, Russian Federation.

Publikováno v: Oncotarget [Oncotarget] 2017 Apr 10; Vol. 8 (32), pp. 52304-52320. Date of Electronic Publication: 2017 Apr 10 (Print Publication: 2017).

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.